Skip to main content
. 2022 Dec 26;12:22368. doi: 10.1038/s41598-022-25485-8

Figure 1.

Figure 1

Age-standardized incidence rates (ASIR) for females (a) and males (b), age-standardized mortality rates for females (ASMR) (c) and males (d), mortality-to-incidence ratios (MIR) for females (e) and males (f), and disability-adjusted life years (DALYs) for females (g) and males (h) for kidney cancer (KC) for EU 15 + countries in 2019. All indices are per 100,000 population.